RxSight Inc (RXST)
50.85
-3.88
(-7.09%)
USD |
NASDAQ |
Nov 07, 16:00
48.00
-2.85
(-5.60%)
After-Hours: 05:33
RxSight Revenue (TTM): 115.18M for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 115.18M |
| March 31, 2024 | 101.10M |
| December 31, 2023 | 89.08M |
| September 30, 2023 | 76.59M |
| June 30, 2023 | 67.00M |
| March 31, 2023 | 57.55M |
| December 31, 2022 | 49.00M |
| September 30, 2022 | 41.34M |
| Date | Value |
|---|---|
| June 30, 2022 | 34.51M |
| March 31, 2022 | 28.05M |
| December 31, 2021 | 22.59M |
| September 30, 2021 | 19.08M |
| June 30, 2021 | 17.46M |
| March 31, 2021 | 15.27M |
| December 31, 2020 | 14.68M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
14.68M
Minimum
Dec 2020
115.18M
Maximum
Jun 2024
49.90M
Average
41.34M
Median
Sep 2022
Revenue (TTM) Benchmarks
| Tandem Diabetes Care Inc | 854.35M |
| Twist Bioscience Corp | 295.21M |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | 110.94M |
| Catheter Precision Inc | 0.436M |